2026 ICD-10-CM Diagnosis Code R97.8Other abnormal tumor markers
ICD-10-CM Codes›R00–R99›R97›R97
- Billable — Valid for Submission
- Not Chronic
R97.8 is a billable ICD-10-CM diagnosis code for other abnormal tumor markers. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 947 through 948. As a symptom code, it should not be used as a principal diagnosis once a related definitive diagnosis has been established. Coders also document this condition as cancer antigen 125 above reference range. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Abnormal findings without diagnosis.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Cancer antigen 125 above reference range
- Cancer antigen 19-9 above reference range
- Endometrial cancer genetic marker of susceptibility positive
- High tumor mutational burden
- Ovarian cancer genetic marker of susceptibility positive
- Prostate specific antigen outside reference range
- Tumor mutational burden
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- Abnormal, abnormality, abnormalities - See Also: Anomaly;
- tumor marker NEC - R97.8
- tumor associated antigens [TAA] NEC - R97.8
- tumor specific antigens [TSA] NEC - R97.8
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Abnormal, abnormality, abnormalities
- tumor marker NEC
- Elevated, elevation
- tumor associated antigens [TAA] NEC
- Elevated, elevation
- tumor specific antigens [TSA] NEC
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Patient EducationClinical
Laboratory Tests
Laboratory tests check a sample of your blood, urine, or body tissues. A technician or your doctor analyzes the test samples to see if your results fall within the normal range. The tests use a range because what is normal differs from person to person. Many factors affect test results. These include:
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert R97.8 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About R97.8Overview
Is R97.8 (Abnormal tumor markers) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report other abnormal tumor markers on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does R97.8 group to?
When other abnormal tumor markers is the principal diagnosis on an inpatient stay, it groups to MS-DRG 947, 948, with relative weights from 0.8005 to 1.2694 depending on complications. Higher weights mean higher Medicare reimbursement.
Can R97.8 be a principal diagnosis?
Use it with care. This is a symptom code, so once a definitive diagnosis explaining the other abnormal tumor markers is established, that condition takes the principal position instead.
What is the ICD-9 equivalent of R97.8?
Under the General Equivalence Mappings, other abnormal tumor markers converts to ICD-9-CM 795.89 (abnorml tumor marker NEC). The mapping is a direct match.
Footnotes
[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.
